Segui
Alexander Najibi
Alexander Najibi
PhD, Harvard University; Scientist II, Kelonia Therapeutics
Email verificata su keloniatx.com
Titolo
Citata da
Citata da
Anno
Racial discrimination in face recognition technology
A Najibi
Science in the News 24, 2020
1672020
Matrix viscoelasticity controls spatiotemporal tissue organization
A Elosegui-Artola, A Gupta, AJ Najibi, BR Seo, R Garry, CM Tringides, ...
Nature materials 22 (1), 117-127, 2023
1662023
Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors
H Wang, AJ Najibi, MC Sobral, BR Seo, JY Lee, D Wu, AW Li, ...
Nature communications 11 (1), 5696, 2020
1442020
A biomaterial-based vaccine eliciting durable tumour-specific responses against acute myeloid leukaemia
NJ Shah, AJ Najibi, TY Shih, AS Mao, A Sharda, DT Scadden, DJ Mooney
Nature Biomedical Engineering 4 (1), 40-51, 2020
1002020
Cell and tissue engineering in lymph nodes for cancer immunotherapy
AJ Najibi, DJ Mooney
Advanced drug delivery reviews 161, 42-62, 2020
662020
Acetalated dextran nanoparticles loaded into an injectable alginate cryogel for combined chemotherapy and cancer vaccination
T Bauleth‐Ramos, TY Shih, MA Shahbazi, AJ Najibi, AS Mao, D Liu, ...
Advanced Functional Materials 29 (35), 1903686, 2019
652019
CD4 T-cells regulate angiogenesis and myogenesis
BJ Kwee, E Budina, AJ Najibi, DJ Mooney
Biomaterials 178, 109-121, 2018
592018
Active tissue adhesive activates mechanosensors and prevents muscle atrophy
S Nam, BR Seo, AJ Najibi, SL McNamara, DJ Mooney
Nature materials 22 (2), 249-259, 2023
512023
Treating ischemia via recruitment of antigen-specific T cells
BJ Kwee, BR Seo, AJ Najibi, AW Li, TY Shih, D White, DJ Mooney
Science advances 5 (7), eaav6313, 2019
392019
Adoptive T cell transfer and host antigen-presenting cell recruitment with cryogel scaffolds promotes long-term protection against solid tumors
K Adu-Berchie, JM Brockman, Y Liu, TW To, DKY Zhang, AJ Najibi, ...
Nature Communications 14 (1), 3546, 2023
292023
Ultrasound-triggered release reveals optimal timing of CpG-ODN delivery from a cryogel cancer vaccine
TY Shih, AJ Najibi, AL Bartlett, AW Li, DJ Mooney
Biomaterials 279, 121240, 2021
232021
Scaffold vaccines for generating robust and tunable antibody responses
AJ Najibi, MO Dellacherie, TY Shih, EJ Doherty, DA White, ...
Advanced Functional Materials 32 (16), 2110905, 2022
212022
Cryogel vaccines effectively induce immune responses independent of proximity to the draining lymph nodes
AJ Najibi, TY Shih, DJ Mooney
Biomaterials 281, 121329, 2022
152022
Targeting tumor extracellular matrix activates the tumor-draining lymph nodes
AJ Najibi, TY Shih, DKY Zhang, J Lou, MC Sobral, H Wang, ...
Cancer Immunology, Immunotherapy 71 (12), 2957-2968, 2022
92022
Durable lymph-node expansion is associated with the efficacy of therapeutic vaccination
AJ Najibi, RS Lane, MC Sobral, G Bovone, S Kang, BR Freedman, ...
Nature Biomedical Engineering, 1-17, 2024
82024
Chemotherapy dose shapes the expression of immune-interacting markers on cancer cells
AJ Najibi, K Larkin, Z Feng, N Jeffreys, MT Dacus, Y Rustagi, FS Hodi, ...
Cellular and Molecular Bioengineering 15 (6), 535-551, 2022
42022
Immune‐responsive biodegradable scaffolds for enhancing neutrophil regeneration
MD Kerr, DA McBride, WT Johnson, AK Chumber, AJ Najibi, BR Seo, ...
Bioengineering & Translational Medicine 8 (1), e10309, 2023
32023
Lymph node expansion predicts magnitude of vaccine immune response
AJ Najibi, RS Lane, MC Sobral, BR Freedman, JG Estupinan, ...
bioRxiv, 2022.10. 25.513749, 2022
22022
Biomaterial-based antigen free vaccine and the use thereof
AJ Najibi, NJ Shah, H Wang, DJ Mooney, DT Scadden
US Patent App. 17/701,270, 2022
22022
IL-2/anti-IL-2 antibody complexes augment immune responses to therapeutic cancer vaccines
MC Sobral, L Cabizzosu, SJ Kang, K Ruark, AJ Najibi, RS Lane, E Vitner, ...
Proceedings of the National Academy of Sciences 121 (48), e2322356121, 2024
12024
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20